Is Tectonic Therapeutics profitable?

Tectonic Therapeutics is not currently profitable: it reported a net loss of $83.5M over the trailing twelve months.

What is Tectonic Therapeutics's earnings per share?

Tectonic Therapeutics's diluted EPS over the trailing twelve months is $-4.46.

Where does Tectonic Therapeutics's income statement data come from?

Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Tectonic Therapeutics TECX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Research and development	$63.49M+53.5%	$41.37M-0.1%	$41.43M-42.6%	$72.19M-13.1%
General and administrative	$20.55M+23.4%	$16.65M+19.7%	$13.91M-58.2%	$33.25M-6.9%
Other operating expenses	$84.04M+44.8%	$58.02M+4.8%	$55.34M-47.5%	$105.43M-11.3%
Total operating expenses	$84.04M+44.8%	$58.02M+4.8%	$55.34M-47.5%	$105.43M-11.3%
Operating income	-$84.04M-44.8%	-$58.02M-4.8%	-$55.34M+47.5%	-$105.43M+11.3%
Interest expense	$63K-40.6%	$106K-30.3%	$152K—	——
Interest income	$11.3M+165%	$4.26M+507%	$702K—	——
Other income (expense), net	$11.12M+31,657%	$35K-98.3%	$2M—	——
Income before income taxes	-$72.92M-25.8%	-$57.98M—	——	——
Income tax expense	$17.14M+12.3%	$15.27M—	——	$0—
Net income	-$74.15M-27.9%	-$57.98M-35.4%	-$42.82M+59.6%	-$105.89M+11.1%
Diluted earnings per share	-$4.05—	——	-$22.40-829%	-$2.41+13.6%
Basic earnings per share	-$4.05—	——	-$22.40-829%	-$2.41+13.3%
Weighted-average shares, diluted	72.9M+165%	27.5M-42.5%	47.9M-72.6%	174.9M+2.5%
Weighted-average shares, basic	72.9M+165%	27.5M-42.5%	47.9M-72.6%	174.9M—
Foreign currency translation gains (losses)	-$105K-10,600%	$1K+109%	-$11K—	——
Tax expense (benefit)	$74.26M+28.1%	$57.98M+35.4%	$42.83M—	——
Other income, net (Note 6)	-$119K+76.7%	-$510K-224%	$412K—	——
EBIT	-$84.04M-44.8%	-$58.02M-4.8%	-$55.34M+47.5%	-$105.43M+11.3%
EBITDA	-$82.66M-46.6%	-$56.37M-4.4%	-$53.98M+48.1%	-$104.01M+11.4%
EBITDA	-$82.66M-46.6%	-$56.37M-4.4%	-$53.98M+48.1%	-$104.01M+11.4%
EBIT	-$84.04M-44.8%	-$58.02M-4.8%	-$55.34M+47.5%	-$105.43M+11.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Tectonic Therapeutics profitable?: Tectonic Therapeutics is not currently profitable: it reported a net loss of $83.5M over the trailing twelve months.
What is Tectonic Therapeutics's earnings per share?: Tectonic Therapeutics's diluted EPS over the trailing twelve months is $-4.46.
Where does Tectonic Therapeutics's income statement data come from?: Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.